SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Inga Liepelt-Scarfone, Stefanie Lerche, Stefanie Behnke, Jana Godau, Alexandra Gaenslen, Christoph Pausch, Klaus Fassbender, Kathrin Brockmann, Karin Srulijes, Heiko Huber, Isabel Wurster, Daniela Berg, Clinical characteristics related to worsening of motor function assessed by the Unified Parkinson’s Disease Rating Scale in the elderly population, Journal of Neurology, 2015, 262, 2, 451

    CrossRef

  2. 2
    G. Reinoso, J. C. Allen, W.-L. Au, S.-H. Seah, K.-Y. Tay, L. C. S. Tan, Clinical evolution of Parkinson's disease and prognostic factors affecting motor progression: 9-year follow-up study, European Journal of Neurology, 2015, 22, 3
  3. 3
    Heather B. Rigby, Brittany N. Dugger, Joseph G. Hentz, Charles H. Adler, Thomas G. Beach, Holly A. Shill, Erika Driver-Dunckley, Marwan N. Sabbagh, Lucia I. Sue, John N. Caviness, Clinical Features of Patients with Concomitant Parkinson's Disease and Progressive Supranuclear Palsy Pathology, Movement Disorders Clinical Practice, 2015, 2, 1
  4. 4
    Roberto Erro, Marina Picillo, Marianna Amboni, Marcello Moccia, Carmine Vitale, Katia Longo, Maria Teresa Pellecchia, Gabriella Santangelo, Pablo Martinez-Martin, K. Ray Chaudhuri, Paolo Barone, Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease, Movement Disorders, 2015, 30, 2
  5. 5
    Jiin-Ling Jiang, Shu-Fen Lo, Sheng-Tzung Tsai, Shin-Yuan Chen, A systematic review of the impact of subthalamic nucleus stimulation on the quality of life of patients with Parkinson's disease, Tzu Chi Medical Journal, 2014, 26, 1, 15

    CrossRef

  6. 6
    Shang-Ming Chiou, Yu-Chin Lin, Ming-Kuei Lu, Chon-Haw Tsai, Bilateral subthalamic stimulation for advanced Parkinson disease: early experience at an Eastern center, Neurological Sciences, 2014,

    CrossRef

  7. 7
    Christian R. Baumann, Ulrike Held, Philipp O. Valko, Miriam Wienecke, Daniel Waldvogel, Body side and predominant motor features at the onset of Parkinson's disease are linked to motor and nonmotor progression, Movement Disorders, 2014, 29, 2
  8. 8
    Jamie M. Sheard, Malnutrition and Neurodegenerative Diseases, Current Nutrition Reports, 2014, 3, 2, 102

    CrossRef

  9. 9
    Michael Sommerauer, Philipp O. Valko, Esther Werth, Rositsa Poryazova, Sabrina Hauser, Christian R. Baumann, Revisiting the impact of REM sleep behavior disorder on motor progression in Parkinson's disease, Parkinsonism & Related Disorders, 2014, 20, 4, 460

    CrossRef

  10. 10
    Valerie E. Kelly, Anne Shumway-Cook, The ability of people with Parkinson’s disease to modify dual-task performance in response to instructions during simple and complex walking tasks, Experimental Brain Research, 2014, 232, 1, 263

    CrossRef

  11. 11
    Ali Shalash, Athanasia Alexoudi, Karina Knudsen, Jens Volkmann, Maximilian Mehdorn, Günther Deuschl, The impact of age and disease duration on the long term outcome of neurostimulation of the subthalamic nucleus, Parkinsonism & Related Disorders, 2014, 20, 1, 47

    CrossRef

  12. You have free access to this content12
    Daniela Berg, Ronald B. Postuma, Bastiaan Bloem, Piu Chan, Bruno Dubois, Thomas Gasser, Christopher G. Goetz, Glenda M. Halliday, John Hardy, Anthony E. Lang, Irene Litvan, Kenneth Marek, José Obeso, Wolfgang Oertel, C. Warren Olanow, Werner Poewe, Matthew Stern, Günther Deuschl, Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease, Movement Disorders, 2014, 29, 4
  13. 13
    G. W. Duncan, A. J. Yarnall, S. Marrinan, D. J. Burn, New horizons in the pathogenesis, assessment and management of movement disorders, Age and Ageing, 2013, 42, 1, 2

    CrossRef

  14. 14
    Eva Pirogovsky, Mercedes Martinez-Hannon, Dawn M. Schiehser, Stephanie L. Lessig, David D. Song, Irene Litvan, J. Vincent Filoteo, Predictors of performance-based measures of instrumental activities of daily living in nondemented patients with Parkinson’s disease, Journal of Clinical and Experimental Neuropsychology, 2013, 35, 9, 926

    CrossRef

  15. 15
    Dominique C. Olthof, Pieter Joosse, Cornelis H. van der Vlies, Rob J. de Haan, J. Carel Goslings, Prognostic factors for failure of nonoperative management in adults with blunt splenic injury, Journal of Trauma and Acute Care Surgery, 2013, 74, 2, 546

    CrossRef

  16. 16
    Martijn L.T.M. Müller, Kirk A. Frey, Myria Petrou, Vikas Kotagal, Robert A. Koeppe, Roger L. Albin, Nicolaas I. Bohnen, β-amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia, Movement Disorders, 2013, 28, 3
  17. 17
    Valerie E. Kelly, Alexis J. Eusterbrock, Anne Shumway-Cook, A Review of Dual-Task Walking Deficits in People with Parkinson's Disease: Motor and Cognitive Contributions, Mechanisms, and Clinical Implications, Parkinson's Disease, 2012, 2012, 1

    CrossRef

  18. 18
    Thuy C. Vu, John G. Nutt, Nicholas H. G. Holford, Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's disease, British Journal of Clinical Pharmacology, 2012, 74, 2
  19. 19
    Chihiro Ohye, Yoshinori Higuchi, Toru Shibazaki, Takao Hashimoto, Toru Koyama, Tatsuo Hirai, Shinji Matsuda, Toru Serizawa, Tomokatsu Hori, Motohiro Hayashi, Taku Ochiai, Hirofumi Samura, Katsumi Yamashiro, Gamma Knife Thalamotomy for Parkinson Disease and Essential Tremor, Neurosurgery, 2012, 70, 3, 526

    CrossRef

  20. 20
    Connie Marras, How will epidemiology shape our knowledge of the patterns of disease progression in Parkinson’s disease?, Basal Ganglia, 2012, 2, 4, 171

    CrossRef

  21. 21
    Barbara Jasinska-Myga, Michael G. Heckman, Christian Wider, John D. Putzke, Zbigniew K. Wszolek, Ryan J. Uitti, Loss of ability to work and ability to live independently in Parkinson’s disease, Parkinsonism & Related Disorders, 2012, 18, 2, 130

    CrossRef

  22. 22
    Connie Marras, David Oakes, Piecing together the puzzle of progression and mortality in Parkinson's disease, British Journal of Clinical Pharmacology, 2012, 74, 2
  23. 23
    Matilde Leonardi, Alberto Raggi, Marco Pagani, Francesco Carella, Paola Soliveri, Alberto Albanese, Luigi Romito, Relationships between disability, quality of life and prevalence of nonmotor symptoms in Parkinson’s disease, Parkinsonism & Related Disorders, 2012, 18, 1, 35

    CrossRef

  24. 24
    Valerie E. Kelly, Alexis J. Eusterbrock, Anne Shumway-Cook, The Effects of Instructions on Dual-Task Walking and Cognitive Task Performance in People with Parkinson's Disease, Parkinson's Disease, 2012, 2012, 1

    CrossRef

  25. 25
    Toru Baba, Atsushi Takeda, Akio Kikuchi, Yoshiyuki Nishio, Yoshiyuki Hosokai, Kazumi Hirayama, Takafumi Hasegawa, Naoto Sugeno, Kyoko Suzuki, Etsuro Mori, Shoki Takahashi, Hiroshi Fukuda, Yasuto Itoyama, Association of olfactory dysfunction and brain. Metabolism in Parkinson's disease, Movement Disorders, 2011, 26, 4
  26. 26
    Sze-Ee Soh, Meg E. Morris, Jennifer L. McGinley, Determinants of health-related quality of life in Parkinson’s disease: A systematic review, Parkinsonism & Related Disorders, 2011, 17, 1, 1

    CrossRef

  27. 27
    Dee E. Silver, Philip O. Buck, Determining the Efficacy of Rasagiline in Reducing Bradykinesia Among Parkinson's Disease Patients: A Review, International Journal of Neuroscience, 2011, 121, 9, 485

    CrossRef

  28. 28
    Michael J. Devine, Hélène Plun-Favreau, Nicholas W. Wood, Parkinson's disease and cancer: two wars, one front, Nature Reviews Cancer, 2011, 11, 11, 812

    CrossRef

  29. 29
    A. Merola, M. Zibetti, S. Angrisano, L. Rizzi, V. Ricchi, C. A. Artusi, M. Lanotte, M. G. Rizzone, L. Lopiano, Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients, Brain, 2011, 134, 7, 2074

    CrossRef

  30. 30
    Jamie M Sheard, Susan Ash, Peter A Silburn, Graham K Kerr, Prevalence of malnutrition in Parkinson's disease: a systematic review, Nutrition Reviews, 2011, 69, 9
  31. 31
    Bart Post, Dino Muslimovic, Nan van Geloven, Johannes D. Speelman, Ben Schmand, Rob J. de Haan, Progression and prognostic factors of motor impairment, disability and quality of life in newly diagnosed Parkinson's disease, Movement Disorders, 2011, 26, 3
  32. 32
    Jens Klotsche, Jens Peter Reese, Yaroslav Winter, Wolfgang H. Oertel, Hyacinth Irving, Hans-Ulrich Wittchen, Juergen Rehm, Richard Dodel, Trajectory Classes of Decline in Health-Related Quality of Life in Parkinson's Disease: A Pilot Study, Value in Health, 2011, 14, 2, 329

    CrossRef

  33. 33
    Jens Kuhle, Axel Petzold, What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 2: chronic progressive and relapsing disease, Expert Opinion on Medical Diagnostics, 2011, 5, 5, 393

    CrossRef

  34. 34
    Stanley Fahn, Joseph Jankovic, Mark Hallett, Principles and Practice of Movement Disorders, 2011,

    CrossRef

  35. 35
    Jose A Obeso, Maria C Rodriguez-Oroz, Christopher G Goetz, Concepcion Marin, Jeffrey H Kordower, Manuel Rodriguez, Etienne C Hirsch, Matthew Farrer, Anthony H V Schapira, Glenda Halliday, Missing pieces in the Parkinson's disease puzzle, Nature Medicine, 2010, 16, 6, 653

    CrossRef

  36. 36
    Donald L. Bliwise, Lynn Marie Trotti, Sophia A. Greer, Jorge J. Juncos, David B. Rye, Phasic muscle activity in sleep and clinical features of Parkinson disease, Annals of Neurology, 2010, 68, 3
  37. 37
    Janis M. Miyasaki, Using Evidence-Based Medicine in Neurology, Neurologic Clinics, 2010, 28, 2, 489

    CrossRef

  38. 38
    Micaela Morelli, Anna R. Carta, Anil Kachroo, Michael A. Schwarzschild, Recent Advances in Parkinson’s Disease: Basic Research, 2010,

    CrossRef

  39. 39
    Cristina Sampaio, Can focusing on UPDRS Part II make assessments of Parkinson disease progression more efficient?, Nature Clinical Practice Neurology, 2009, 5, 3, 130

    CrossRef

  40. 40
    William K. Gray, Brian H. Wood, Richard W. Walker, Do autonomic function tests in people with Parkinson's disease predict survival rates at 7 years follow-up?, Movement Disorders, 2009, 24, 16
  41. 41
    William K. Gray, Anthony Hildreth, Julie A. Bilclough, Brian H. Wood, Katherine Baker, Richard W. Walker, Physical assessment as a predictor of mortality in people with Parkinson's disease: A study over 7 years, Movement Disorders, 2009, 24, 13
  42. 42
    Daniel A. Nation, Heather L. Katzen, Spyridon Papapetropoulos, Blake K. Scanlon, Bonnie E. Levin, Subthreshold depression in Parkinson's disease, International Journal of Geriatric Psychiatry, 2009, 24, 9
  43. 43
    B. Post, J. D. Speelman, R. J. Haan, Clinical heterogeneity in newly diagnosed Parkinson’s disease, Journal of Neurology, 2008, 255, 5, 716

    CrossRef

  44. 44
    Guido Alves, Elin Bjelland Forsaa, Kenn Freddy Pedersen, Michaela Dreetz Gjerstad, Jan Petter Larsen, Epidemiology of Parkinson’s disease, Journal of Neurology, 2008, 255, S5, 18

    CrossRef

  45. 45
    L. Ishihara-Paul, N. W. J. Wainwright, K.-T. Khaw, R. N. Luben, A. A. Welch, N. E. Day, C. Brayne, P. G. Surtees, Prospective association between emotional health and clinical evidence of Parkinson’s disease, European Journal of Neurology, 2008, 15, 11
  46. 46
    Yvette A. M. Grimbergen, Arlène D. Speelman, Marjolein A. van der Marck, Yvonne Schoon, Bastiaan R. Bloem, Gait, Postural Instability, and Freezing,